Tandem Mass Tag-Based Proteomic Analysis of Normal and Degenerated Human Intervertebral Discs
Yang Fu,Xiao-Qin Huang,Hang-Bo Qu,Yan Zhi Ge,Xuan-Liang Ru
DOI: https://doi.org/10.2147/jpr.s449044
IF: 2.8319
2024-03-27
Journal of Pain Research
Abstract:Yang Fu, &ast Xiao-Qin Huang, &ast Hang-Bo Qu, Yan Zhi Ge, Xuan-Liang Ru Department of Orthopedics, Zhejiang Hospital, Hangzhou, Zhejiang Province, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xuan-Liang Ru, Department of Orthopedics, Zhejiang Hospital, No. 1229 Gudun Road, Hangzhou, Zhejiang Province, 310013, People's Republic of China, Tel +86-133-3612-4875, Email Background: Intervertebral disc degeneration (IVDD) is the main cause of low back pain (LBP), but the specific regulatory factors, pathways and specific molecular mechanisms remain unclear. Methods: We identified and quantitatively analyzed Pfirrmann Grade II (n=3) and Pfirrmann Grade IV (n=3) pulposus samples via MRI. The differential abundance of proteins in the samples was determined and quantitatively analyzed by relative and absolute quantitative analysis of the isotope marker levels combined with the liquid chromatography–tandem mass spectrometry (LC‒MSMS/MS). Results: A total of 70 proteins (30 significantly increased proteins (> 1.2-fold change) and 40 significantly decreased proteins (< 0.8-fold change)) showed different levels among the groups. Kyoto Encyclopedia of Genes and Genomes and Gene Ontology (GO) enrichment analyses and Western blot analysis showed that CYCS, RAC1, and PSMD14 may play important roles in IVDD and that Epstein‒Barr virus infection, viral myocarditis, colorectal cancer, nonalcoholic fatty liver disease (NAFLD) and amyotrophic lateral sclerosis (ALS) are the main pathways involved in IVDD. Conclusion: CYCS, RAC1 and PSMD14 may play important roles in IVDD, and Epstein‒Barr virus infection, viral myocarditis, colorectal cancer, NAFLD and ALS may be the main pathways involved in IVDD. Keywords: TMT, LC‒MS/MS, proteomics, low back pain, nucleus pulposus Low back pain (LBP) is an important disease that endangers the lives of people worldwide and has an incidence greater than 70%, 1 but its pathogenic mechanism remains unclear. Lumbar disc degeneration is an important factor leading to LBP, especially in middle-aged and elderly patients. 2 The mechanism underlying the occurrence and development of lumbar intervertebral disc degeneration (IVDD) is complex, and age is the main risk factor. 3 The currently available drugs can alleviate only the clinical manifestations of LBP but cannot eliminate the underlying problem. Studying aging-related degenerative IVDD is key to identifying a new strategy for preventing and treating IVDD. 4 IVDD is initiated in the nucleus pulposus (NP), which is located at the center of a disc. 5 Degenerative lesions in the lumbar spine generally have no obvious clinical manifestations but are accompanied by loss of water and proteoglycans. In general, degenerated discs become fibrotic and cannot absorb shock. Moreover, age-related IVDD is attributed to rapid changes in the anatomic and pathophysiological characteristics after birth. 6 According to magnetic resonance imaging (MRI), lumbar disc degeneration can be divided into five grades according to the Pfirrmann grade: Grade I indicates a normal degree of degeneration, Grade II is considered to indicate mild degeneration, Grade III is thought to indicate moderate degeneration, and Grades IV and V denote severe degeneration. 7,8 The aging of organisms and the resulting pathophysiological changes can be detected at the protein level. However, the previous studies on age-related IVDD have been limited to a few proteins and pathways. 9 At present, experiments are commonly used, but their results do not directly reflect the severity of IVDD. 10 In general, few studies have performed a comprehensive evaluation of the protein profile of lumbar intervertebral discs, especially human NP specimens. 11 Proteomics is a cross-disciplinary field in which the composition, function and interrelation of proteins are studied in their entirety. Differential proteome analysis is a good method for evaluating the protein levels in samples because it enables protein screening and identification of the whole protein network in samples. 12 With the continuous development of proteomics technology, stable isotope labeling, especially tandem mass tag (TMT) labeling, combined with mass spectrometry (MS) has become the main method used for protein quantitative analysis. 13 This method has tremendously facilitated the study of the mechanisms linked to degenerate diseases. Compared with genomics and transcriptomics, quantitative proteomics is an ideal tool for obtaining insights into overall proteome differences. Potential biomarkers and mechanisms can be elucidated by proteomi -Abstract Truncated-
clinical neurology